(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

Principle Coordinates Analysis (PCoA) projected onto 2 dimensions between pol-wgs mixtures and nFL genome, full dataset by August Guang (9975678)

Principle Coordinates Analysis (PCoA) projected onto 2 dimensions between pol-wgs mixtures and nFL genome, subset dataset by August Guang (9975678)

Phylogenetic distance between partial pol-wgs mixtures and nFL genome for subset dataset. by August Guang (9975678)

Phylogenetic distance between partial pol-wgs mixtures and nFL genome for full dataset. by August Guang (9975678)

HFD decreases ITM and alters metabolic homeostasis. by Tong Yue (6033305)

“…Two-way ANOVA, n.s., not significant, ** p < 0.01). <b>(F)</b> Long-term memory (LTM) was significantly decreased in the HFD group. …”

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Data from: Spillage and food dust do not decrease efficacy of long-lasting insecticide-incorporated netting against stored product insects by Sabita Ranabhat (17484660)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Analyzing the event log reveals that A) Therapist chart checks take a long time to complete, B) specific notations for treatment techniques are infrequently used and may be redunda... by Mohammad Bakhtiari (11838264)

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

Screening for gHgLgO interaction partners reveals decreased binding of the gO249 mutant to cell surfaces. by Lena Thiessen (17605194)

Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

Workflow for alignment dataset generation and phylogenetic analysis. by August Guang (9975678)

Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”